Bio-Works Technologies
4,07 SEK
-4,01 %
Mindre end 1K følgere
BIOWKS
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
-4,01 %
+27,19 %
+30,03 %
+55,34 %
+56,54 %
+175,00 %
-65,08 %
-66,11 %
-52,63 %
Bio-Works Technologies operates in biotechnology. The company develops products that separate and purify molecules in the production of pharmaceuticals. The technology is based on chromatography, which is intended to handle the drug substance. Customers are found in the European market where the products are sold via distribution partners and to companies in the pharmaceutical industry, as well as research institutes and universities. The company was founded in 2006 and has its headquarters in Uppsala.
Læs mereMarkedsværdi
407,04 mio. SEK
Aktieomsætning
373,62 t SEK
Omsætning
62,5 mio.
EBIT %
-28,03 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning mio.
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
4.6
2026
Generalforsamling '26
21.8
2026
Delårsrapport Q2'26
6.11
2026
Delårsrapport Q3'26
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Bio-Works Technologies AB: Bio-Works receives order for WorkBeads 40S from contract manufacturer in Europe
Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 6 of 11
Bliv en del af Inderes community
Gå ikke glip af noget - opret en konto og få alle de mulige fordele
Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer